//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы

126//

Spigelman S.S. et al. Rectal examination in volume determination of carcinoma of the prostate: clinical and anatomical correlations. J Urol. 1986;136:1228. https://www.ncbi.nlm.nih.gov/pubmed/3773095.

Partin A.W. et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol. 1990;143:747. https://www.ncbi.nlm.nih.gov/pubmed/1690309.

Quinn D.I. et al. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Cancer. 2003;97:1884. https://www.ncbi.nlm.nih.gov/pubmed/12673714.

Saliken J.C. et al. Extraprostatic biopsy improves the staging of localized prostate cancer. Can Assoc Radiol J. 2000;51:114. https://www.ncbi.nlm.nih.gov/pubmed/10786920.

Mitterberger M. et al. The value of three-dimensional transrectal ultrasonography in staging prostate cancer. BJU Int. 2007;100:47. https://www.ncbi.nlm.nih.gov/pubmed/17433033.

De Rooij M. et al. Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. Eur Urol. 2016;70:233. https://www.ncbi.nlm.nih.gov/pubmed/26215604.

Stone N.N. et al. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. J Urol. 1998;160:1722. https://www.ncbi.nlm.nih.gov/pubmed/9783940.

Pisansky T.M. et al. Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. Int J Radiat Oncol Biol Phys. 1996;34:33. https://www.ncbi.nlm.nih.gov/pubmed/12118563.

Abuzallouf S. et al. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol. 2004;171:2122. https://www.ncbi.nlm.nih.gov/pubmed/15126770.

Kiss B. et al. Current Status of Lymph Node Imaging in Bladder and Prostate Cancer. Urology. 2016;96:1. https://www.ncbi.nlm.nih.gov/pubmed/26966038.

//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы

//127

Harisinghani M.G. et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491. https://www.ncbi.nlm.nih.gov/pubmed/12815134.

Hovels. A.M. et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63:387. https://www.ncbi.nlm.nih.gov/pubmed/18325358.

Brogsitter C. et al. 18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients. Eur J Nucl Med Mol Imaging. 2013;40(Suppl 1):S18. https://www.ncbi.nlm.nih.gov/pubmed/23579863. PROSTATE CANCER - UPDATE MARCH 2017 109.

Poulsen M.H. et al. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients. BJU Int. 2012;110:1666. https://www.ncbi.nlm.nih.gov/pubmed/22520686.

Perera M. et al. Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 2016. https://www.ncbi.nlm.nih.gov/pubmed/27363387.

Shen G. et al. Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol. 2014;43:1503. https://www.ncbi.nlm.nih.gov/pubmed/24841276.

Even-Sapir E. et al. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006;47:287. https://www.ncbi.nlm.nih.gov/pubmed/16455635.

Picchio M. et al. [11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy. Eur J Nucl Med Mol Imaging. 2012;39:13. https://www.ncbi.nlm.nih.gov/pubmed/21932120.